These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 35688800)

  • 1. Enhancing the Release Efficiency of a Molecular Chemotherapeutic Prodrug by Photodynamic Therapy.
    Yuan J; Zhou QH; Xu S; Zuo QP; Li W; Zhang XX; Ren TB; Yuan L; Zhang XB
    Angew Chem Int Ed Engl; 2022 Aug; 61(33):e202206169. PubMed ID: 35688800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A promising strategy for synergistic cancer therapy by integrating a photosensitizer into a hypoxia-activated prodrug.
    Yang DC; Yang XZ; Luo CM; Wen LF; Liu JY; Lin Z
    Eur J Med Chem; 2022 Dec; 243():114749. PubMed ID: 36115207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxygen-producing catalase-based prodrug nanoparticles overcoming resistance in hypoxia-mediated chemo-photodynamic therapy.
    Cheng X; He L; Xu J; Fang Q; Yang L; Xue Y; Wang X; Tang R
    Acta Biomater; 2020 Aug; 112():234-249. PubMed ID: 32502633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Programmable therapeutic nanoscale covalent organic framework for photodynamic therapy and hypoxia-activated cascade chemotherapy.
    He H; Du L; Xue H; Wu J; Shuai X
    Acta Biomater; 2022 Sep; 149():297-306. PubMed ID: 35811069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supramolecular micelles as multifunctional theranostic agents for synergistic photodynamic therapy and hypoxia-activated chemotherapy.
    Huang X; Chen T; Mu N; Lam HW; Sun C; Yue L; Cheng Q; Gao C; Yuan Z; Wang R
    Acta Biomater; 2021 Sep; 131():483-492. PubMed ID: 34265471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell membranes targeted unimolecular prodrug for programmatic photodynamic-chemo therapy.
    Yuan J; Peng R; Su D; Zhang X; Zhao H; Zhuang X; Chen M; Zhang X; Yuan L
    Theranostics; 2021; 11(7):3502-3511. PubMed ID: 33537100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An albumin-binding dimeric prodrug nanoparticle with long blood circulation and light-triggered drug release for chemo-photodynamic combination therapy against hypoxia-induced metastasis of lung cancer.
    Luo R; Zhang Z; Han L; Xue Z; Zhang K; Liu F; Feng F; Xue J; Liu W; Qu W
    Biomater Sci; 2021 May; 9(10):3718-3736. PubMed ID: 34008617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tandem activated photodynamic and chemotherapy: Using pH-Sensitive nanosystems to realize different tumour distributions of photosensitizer/prodrug for amplified combination therapy.
    Ji Y; Lu F; Hu W; Zhao H; Tang Y; Li B; Hu X; Li X; Lu X; Fan Q; Huang W
    Biomaterials; 2019 Oct; 219():119393. PubMed ID: 31382206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A light-activatable theranostic combination for ratiometric hypoxia imaging and oxygen-deprived drug activity enhancement.
    Ge L; Tang Y; Wang C; Chen J; Mao H; Jiang X
    Nat Commun; 2024 Jan; 15(1):153. PubMed ID: 38167737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Light-activated PEG deshielding core-shell nanoparticles for enhanced chemo-photodynamic combination therapy.
    Zhang J; Zhang L; Guo J; Yu B; Yu Y; Liu C
    Nanoscale; 2023 Jun; 15(22):9783-9791. PubMed ID: 37199239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An efficient delivery of photosensitizers and hypoxic prodrugs for a tumor combination therapy by membrane camouflage nanoparticles.
    Wang H; Zhang C; Zhang Y; Tian R; Cheng G; Pan H; Cui M; Chang J
    J Mater Chem B; 2020 Apr; 8(14):2876-2886. PubMed ID: 32191252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theranostic Liposomes with Hypoxia-Activated Prodrug to Effectively Destruct Hypoxic Tumors Post-Photodynamic Therapy.
    Feng L; Cheng L; Dong Z; Tao D; Barnhart TE; Cai W; Chen M; Liu Z
    ACS Nano; 2017 Jan; 11(1):927-937. PubMed ID: 28027442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binary dimeric prodrug nanoparticles for self-boosted drug release and synergistic chemo-photodynamic therapy.
    Zhang Y; Pei Q; Yue Y; Xie Z
    J Mater Chem B; 2022 Feb; 10(6):880-886. PubMed ID: 35043826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A hybrid metal-organic framework nanomedicine-mediated photodynamic therapy and hypoxia-activated cancer chemotherapy.
    Jia Z; Gao Y; Ni J; Wu X; Mao Z; Sheng G; Zhu Y
    J Colloid Interface Sci; 2023 Jan; 629(Pt B):379-390. PubMed ID: 36162395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioorthogonal chemistry and illumination controlled programmed size-changeable nanomedicine for synergistic photodynamic and hypoxia-activated therapy.
    Jiang M; Liu Y; Dong Y; Wang K; Yuan Y
    Biomaterials; 2022 May; 284():121480. PubMed ID: 35390710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synchronized activating therapeutic nano-agent: Enhancement and tracing for hypoxia-induced chemotherapy.
    Zhang H; Shi C; Han F; Cai L; Ma H; Long S; Sun W; Du J; Fan J; Chen X; Peng X
    Biomaterials; 2023 Nov; 302():122365. PubMed ID: 37890436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Light-triggered dual-modality drug release of self-assembled prodrug-nanoparticles for synergistic photodynamic and hypoxia-activated therapy.
    Zhao D; Tao W; Li S; Li L; Sun Y; Li G; Wang G; Wang Y; Lin B; Luo C; Wang Y; Cheng M; He Z; Sun J
    Nanoscale Horiz; 2020 May; 5(5):886-894. PubMed ID: 32219262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A photothermal-hypoxia sequentially activatable phase-change nanoagent for mitochondria-targeting tumor synergistic therapy.
    Qu J; Teng D; Sui G; Guan S; Wang Y; Wang Q; Lin Y; Ran H; Wang Z; Wang H
    Biomater Sci; 2020 Jun; 8(11):3116-3129. PubMed ID: 32352102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ROS-sensitive biomimetic nanocarriers modulate tumor hypoxia for synergistic photodynamic chemotherapy.
    Liu H; Jiang W; Wang Q; Hang L; Wang Y; Wang Y
    Biomater Sci; 2019 Aug; 7(9):3706-3716. PubMed ID: 31187794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NIR-II Photoacoustic Imaging-Guided Oxygen Delivery and Controlled Release Improves Photodynamic Therapy for Hepatocellular Carcinoma.
    Zeng S; Chen J; Gao R; Chen R; Xue Q; Ren Y; Liu L; Tang C; Hu H; Zeng N; Wen S; Zhang H; Liu C; Fang C
    Adv Mater; 2024 Jan; 36(4):e2308780. PubMed ID: 37983859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.